Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Cytokinetics (CYTK) Return on Assets: 2009-2025

Historic Return on Assets for Cytokinetics (CYTK) over the last 14 years, with Sep 2025 value amounting to -0.45%.

  • Cytokinetics' Return on Assets fell 7.00% to -0.45% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.45%, marking a year-over-year decrease of 7.00%. This contributed to the annual value of -0.52% for FY2024, which is 5.00% up from last year.
  • Cytokinetics' Return on Assets amounted to -0.45% in Q3 2025, which was up 1.85% from -0.46% recorded in Q2 2025.
  • Cytokinetics' 5-year Return on Assets high stood at -0.22% for Q1 2021, and its period low was -0.69% during Q3 2023.
  • Moreover, its 3-year median value for Return on Assets was -0.46% (2025), whereas its average is -0.51%.
  • In the last 5 years, Cytokinetics' Return on Assets slumped by 43bps in 2023 and then spiked by 31bps in 2024.
  • Over the past 5 years, Cytokinetics' Return on Assets (Quarterly) stood at -0.24% in 2021, then decreased by 9bps to -0.33% in 2022, then crashed by 34bps to -0.67% in 2023, then climbed by 27bps to -0.40% in 2024, then dropped by 7bps to -0.45% in 2025.
  • Its Return on Assets stands at -0.45% for Q3 2025, versus -0.46% for Q2 2025 and -0.45% for Q1 2025.